This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, Merck + Co., Inc.. Active years: 2005.
Company Filing History:
1 out of 3,795 
1 out of 4,770 
Years Active: 2005
Title: Anthony Rosen: Innovator in Autoimmune Research
Introduction: Anthony Rosen, based in Columbia, MD, is a notable inventor in the field of autoimmune research. With a singular patented innovation to his name, he has made significant contributions to understanding and treating conditions associated with autoimmune responses.
Latest Patents: Anthony Rosen holds a patent titled "Autoantigenic fragments, methods and assays." This invention provides a systematic method for producing autoantigens and compositions comprising autoantigenic fragments. It also outlines methods for utilizing these fragments in treating conditions linked to autoimmune responses, alongside assays designed for the detection and assessment of such responses.
Career Highlights: Throughout his career, Anthony Rosen has been affiliated with prominent institutions, including Merck & Company, Inc. and The Johns Hopkins University. His work in these organizations has allowed him to advance research in immunology and develop innovative solutions for complex health issues.
Collaborations: Among his notable collaborators are Livia Angela Casciola-Rosen and Donald W. Nicholson. Their collective efforts have contributed to the development and refinement of his patented methodologies and assays, furthering the understanding of autoimmune diseases.
Conclusion: Anthony Rosen stands out as an essential figure in autoimmune research, with his patent showcasing the potential for innovative treatments in this vital field. His collaborations and career accomplishments reflect a dedicated commitment to advancing scientific knowledge and improving patient outcomes.